Patent · US Active

Compositions and methods for antibodies targeting complement protein C5

US8883158B2 · kind B2 · utility

30Cited by

7References

18Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Beate Diefenbach-Streiber · Windach, DE
Adina Eberth · Munich, DE
Braydon Charles Guild · Concord, US
Yong-In Kim · Westborough, US
Michael Roguska · Cambridge, US
Igor Splawski · Winchester, US

Key dates

Filing date	Jul 25, 2012
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Jul 25, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.